IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
208.05
-1.12 (-0.53%)
Nov 4, 2024, 12:39 PM EST - Market open
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $37.50 billion as of November 4, 2024. Its market cap has increased by 9.65% in one year.
Market Cap
37.50B
Enterprise Value
50.20B
1-Year Change
9.65%
Ranking
Category
Stock Price
$206.60
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $37.50B, an increase of 587.06%. That is a compound annual growth rate of 18.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 37.96B | -10.10% |
| Dec 29, 2023 | 42.23B | 10.96% |
| Dec 30, 2022 | 38.06B | -29.39% |
| Dec 31, 2021 | 53.90B | 56.91% |
| Dec 31, 2020 | 34.35B | 14.58% |
| Dec 31, 2019 | 29.98B | 27.57% |
| Dec 31, 2018 | 23.50B | 13.60% |
| Dec 29, 2017 | 20.69B | 10.50% |
| Dec 30, 2016 | 18.72B | 121.52% |
| Dec 31, 2015 | 8.45B | 12.33% |
| Dec 31, 2014 | 7.52B | 25.93% |
| Dec 31, 2013 | 5.97B | 9.47% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical | 44.26B |
| Haleon | 43.64B |
| Edwards Lifesciences | 40.69B |
| GE HealthCare Technologies | 39.73B |
| Agilent Technologies | 39.33B |
| ResMed | 35.86B |
| argenx SE | 35.78B |
| Alnylam Pharmaceuticals | 35.33B |